Kestra Advisory Services’s Novavax NVAX Stock Holding History

Kestra Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$270K	Buy	+28,636	New	+$257K	﹤0.01%	2860
2022 Q2	–	Sell	-8,946	Closed	-$659K	–	2214
2022 Q1	$659K	Sell	8,946 -4,585	-34%	-$409K	0.01%	1133
2021 Q4	$1.94M	Buy	13,531 +658	+5%	+$113K	0.02%	692
2021 Q3	$2.67M	Buy	12,873 +3,273	+34%	+$721K	0.03%	595
2021 Q2	$2.04M	Buy	9,600 +5,831	+155%	+$1.07M	0.02%	644
2021 Q1	$683K	Buy	3,769 +760	+25%	+$151K	0.01%	1043
2020 Q4	$358K	Buy	+3,009	New	+$320K	﹤0.01%	1373

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Kestra Advisory Services's NVAX Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Novavax (NVAX) in Q2 2026: 28,636 shares worth $270K. The stake represents ﹤0.01% of the portfolio and ranks #2860 among its holdings. This is a return to the name: Kestra Advisory Services previously reported a position in NVAX as recently as Q1 2022.

Kestra Advisory Services first reported a position in NVAX in Q4 2020 and has held it in 7 quarters since. The position peaked at $2.67M in Q3 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Kestra Advisory Services held 28,636 shares of Novavax worth $270K as of Q2 2026.
Novavax was a new Kestra Advisory Services position in Q2 2026.
Novavax made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2860 holding.
Kestra Advisory Services first reported a position in Novavax in Q4 2020 and has held it in 7 quarters since.
Kestra Advisory Services's Novavax position peaked at $2.67M in Q3 2021.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.